Basic Information
| LncRNA/CircRNA Name | LINC00663 |
| Synonyms | NA |
| Region | GRCh38_19:19757366-19776423 |
| Ensemble | ENSG00000266904 |
| Refseq | NR_026956 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioblastoma |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | cell line (A172) |
| Expression Pattern | up-regulated |
| Function Description | As the RT-PCR and qPCR analyses revealed, expression levels of LINC00663 were found to be differentially expressed in various cancer cell lines. LINC00663 showed highest expression in A172 glioblastoma cell line. |
| Pubmed ID | 26743782 |
| Year | 2016 |
| Title | A novel variable exonic region and differential expression of LINC00663 non-coding RNA in various cancer cell lines and normal human tissue samples. |
External Links
| Links for LINC00663 | GenBank HGNC NONCODE |
| Links for glioblastoma | OMIM COSMIC |